Viatris (VTRS) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free VTRS Stock Alerts $11.64 +0.17 (+1.48%) (As of 03:03 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInflation Reduction Act: A Bullish Catalyst For Viatris Inc.seekingalpha.com - April 24 at 6:28 PMViatris Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support Access to Medicine and Healthcarefinanznachrichten.de - April 19 at 12:50 PMViatris to Report First Quarter 2024 Financial Results on May 9, 2024finance.yahoo.com - April 16 at 5:25 PMViatris Inc.: Viatris Appoints Corinne Le Goff as Chief Commercial Officerfinanznachrichten.de - April 15 at 4:22 PMViatris Announces Launch Of Bioequivalent Generic For Copaxone In Canada - Quick Factsmarkets.businessinsider.com - April 15 at 9:24 AMViatris Stock: Way Too Undervalued With $1 Billion Buyback Potentialseekingalpha.com - April 8 at 6:46 PMUK's Theramex sees no impact to HRT products supply after CMA probereuters.com - April 5 at 1:49 PMViatris- Theramex deal for women's care products raises antitrust concerns in U.K.msn.com - April 4 at 12:46 PMViatris Stock (NASDAQ:VTRS), Quotes and News Summarybenzinga.com - April 2 at 10:56 PMTeva and Viatris Granted Opportunity to Contest J&J’s Patent for Schizophrenia Drugmsn.com - April 2 at 7:34 AMTeva and Viatris revives chance to dispute J&J's schizophrenia drug patentmsn.com - April 1 at 2:18 PMTeva, Viatris win new chance to challenge J&J schizophrenia drug patentreuters.com - April 1 at 11:53 AMViatris Announces the Launch of RYZUMVl(TM) (Phentolamine Ophthalmic Solution) 0.75% in the United Statesstockhouse.com - April 1 at 9:08 AMViatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United Statesfinance.yahoo.com - April 1 at 9:08 AMViatris Announces US Commercial Launch Of RYZUMVl 0.75%markets.businessinsider.com - April 1 at 9:08 AMViatris Stock Is Still Worth Buyingseekingalpha.com - March 30 at 8:13 AMViatris Inc. (VTRS) R&D Event (Transcript)seekingalpha.com - March 27 at 3:26 PMViatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipelinefinance.yahoo.com - March 27 at 8:10 AMViatris Q4 Earnings Transcriptmarketbeat.com - March 20 at 7:00 AMIdorsia and Viatris successfully close the transaction for the global research and development collaborationglobenewswire.com - March 18 at 2:00 AMVTRS Oct 2024 18.000 callca.finance.yahoo.com - March 16 at 6:37 AMVTRS Oct 2024 10.000 putca.finance.yahoo.com - March 16 at 6:37 AMVTRS Jul 2024 18.000 callfinance.yahoo.com - March 16 at 6:37 AMViatris generic hypertension drug does not violate J&J patents, US court saysreuters.com - March 15 at 6:04 PMIs Viatris a Great Dividend Stock or Just a Value Trap?fool.com - March 14 at 9:53 AM2 Dirt Cheap Dividend Stocks to Buy and Holdfool.com - March 11 at 9:45 AMUS FDA declines to approve Viatris's injection for multiple sclerosisreuters.com - March 11 at 7:32 AMViatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 5 at 11:26 AMViatris Inc. (VTRS) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 1 at 9:33 AMViatris partners with pharmaceutical company to commercialize 2 productsbizjournals.com - February 28 at 2:47 PMVTRS Earnings: Viatris’ Top Line Declines in Q4; Boosts Buybacks by $1bmsn.com - February 28 at 2:47 PMIdorsia surges 14% after securing $350M from Viatris in an R&D pactinvesting.com - February 28 at 9:46 AMViatris: Q4 Earnings Snapshotsfgate.com - February 28 at 9:46 AMViatris Guides FY24 In Line With Estimates - Updatemarkets.businessinsider.com - February 28 at 9:46 AMViatris EPS of -$0.64, revenue of $3.83B misses by $50Mmsn.com - February 28 at 9:46 AMViatris sets 2024 guidance above consensus; boosts share buybacksmsn.com - February 28 at 9:46 AMViatris Inc (VTRS) Meets 2023 Financial Targets and Sets Course for Continued Growth in 2024finance.yahoo.com - February 28 at 9:46 AMViatris forecasts strong 2024 sales on higher demand for branded drugsreuters.com - February 28 at 8:22 AMViatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidanceprnewswire.com - February 28 at 6:30 AMViatris and Idorsia Enter Into Significant Global Research and Development Collaborationprnewswire.com - February 28 at 1:00 AMIdorsia and Viatris enter into a significant global research and development collaborationglobenewswire.com - February 28 at 1:00 AM3 Overextended Stocks That Need to Slash Their Dividends ASAPinvestorplace.com - February 27 at 3:19 PMViatris is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - February 27 at 2:19 PMViatris Q4 2023 earnings preview: Margins remain under pressuremsn.com - February 27 at 2:19 PM3 Bargain Stocks to Snatch Up Before They Bounce Backinvestorplace.com - February 26 at 4:27 PMViatris Reduces Debt But Faces Growth Hurdlesseekingalpha.com - February 22 at 12:54 AMViatris stock set for seven straight sessions of gainsmsn.com - February 20 at 5:08 PMSPY ETF Update, 2/20/2024msn.com - February 20 at 12:06 PMVTRS Jan 2025 15.000 callfinance.yahoo.com - February 20 at 7:06 AMVTRS Oct 2024 12.000 callfinance.yahoo.com - February 20 at 2:05 AM Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. VTRS Media Mentions By Week VTRS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTRS News Sentiment▼0.700.33▲Average Medical News Sentiment VTRS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTRS Articles This Week▼24▲VTRS Articles Average Week Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BeiGene News Karuna Therapeutics News Teva Pharmaceutical Industries News Dr. Reddy's Laboratories News Sarepta Therapeutics News United Therapeutics News Catalent News BioMarin Pharmaceutical News Legend Biotech News Ascendis Pharma A/S News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTRS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viatris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
